U.S. Markets open in 2 hrs 37 mins

Immunomedics, Inc. (IMMU)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
11.64+0.38 (+3.37%)
At close: 4:00PM EDT
People also watch
IMGNARRYAGENPGNXXOMA
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue6/30/20176/30/20166/30/2015
Total Revenue3,091.253,233.2475,653.091
Cost of Revenue482.6571,159.173264.915
Gross Profit2,608.5932,074.0745,388.176
Operating Expenses
Research Development51,776.39553,492.47141,735.888
Selling General and Administrative29,981.9317,589.6949,871.797
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-79,149.733-59,008.091-46,219.509
Income from Continuing Operations
Total Other Income/Expenses Net-68,615.865298.363244.517
Earnings Before Interest and Taxes-147,765.598-58,709.728-45,974.992
Interest Expense5,479.8215,479.8212,090.75
Income Before Tax-153,245.419-64,189.549-48,065.742
Income Tax Expense20.867-5,053.83358.229
Minority Interest-771.081-710.74-611.974
Net Income From Continuing Ops-153,205.945-59,036.95-48,002.366
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-153,205.945-59,036.95-48,002.366
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-153,205.945-59,036.95-48,002.366